
Biocon Limited has informed the Exchange regarding a press release dated January 07, 2021, titled "Biocon Biologics Receives Rs 555 Cr (USD 75 Million) CapitalInjection from ADQTransaction Values Biocon Biologics at ~USD 4.17 Billion".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated January 07, 2021, titled "Biocon Biologics Receives Rs 555 Cr (USD 75 Million) CapitalInjection from ADQTransaction Values Biocon Biologics at ~USD 4.17 Billion".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon